Skip to Main Content

Paper Details

Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy.
Sci Rep
4
2023
'CpG' sites, Anthracycline, Cas9, CpG, DMP, DMRs, EPIC, EXO6CB, FCHSD2, HumanMethylation, NIPAL2, SYNPO2, anthracycline, anthracycline-induced cardiomyopathy, cardiac dysfunction, cardiomyopathy, cardiovascular, cardiovascular disease, childhood cancer, diabetes, differential methylated regions, differentially methylated probes, doxorubicin, dyslipidemia, gene RORA, genes, hiPSC-CMs, human, human induced pluripotent stem cell cardiomyocytes, hyper-methylated, hypermethylated or hypomethylated CpG sites, hypertension, hypo-methylated probes, intergenic regions, participants, peripheral blood DNA
Author NameAffiliation
David K CrossmanUniversity of Alabama at Birmingham
David K CrossmanUniversity of Alabama at Birmingham
Steve HorvathDavid Geffen School of Medicine, University of California los angeles
Douglas S HawkinsSeattle Children's Hospital
Melissa M HudsonSt. Jude Children's Research Hospital
Joseph P NegliaUniversity of Minnesota
Joseph P NegliaUniversity of Minnesota
Jill P GinsbergChildren's Hospital of Philadelphia
Smita BhatiaInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham
Smita BhatiaUniversity of Alabama at Birmingham
Smita BhatiaInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham
Smita BhatiaUniversity of Alabama at Birmingham
  • 1 - 12

Datasets

Release 1.2